After Leaping 34% Pulike Biological Engineering, Inc. (SHSE:603566) Shares Are Not Flying Under The Radar
Despite an already strong run, Pulike Biological Engineering, Inc. (SHSE:603566) shares have been powering on, with a gain of 34% in the last thirty days. But the gains over the last month weren't
Placo (603566.SH): A total of 1,449,200 shares have been repurchased
Glonghui, May 6, 丨 Placo (603566.SH) announced that as of April 30, 2024, the company had repurchased a total of 1,4492 million shares through centralized bidding transactions, accounting for 0.42% of the company's total share capital. The highest repurchased price was 22.48 yuan/share, the lowest price was 15.47 yuan/share, and the total amount paid was 25,410,025 yuan (excluding transaction fees).
What You Need To Know About The Pulike Biological Engineering, Inc. (SHSE:603566) Analyst Downgrade Today
One thing we could say about the analysts on Pulike Biological Engineering, Inc. (SHSE:603566) - they aren't optimistic, having just made a major negative revision to their near-term (statutory) forec
Placo (603566.SH): Net profit of 27.307 million yuan in the first quarter fell 57.36% year on year
On April 25, GLONGHUI (603566.SH) released its first quarter report. Operating revenue was 235 million yuan, down 23.27% year on year, net profit of 27.307 million yuan, down 57.36% year on year, after deducting non-net profit of 265.35,800 yuan, down 56.10% year on year, with basic earnings of 0.08 yuan per share.
42% Earnings Growth Over 1 Year Has Not Materialized Into Gains for Pulike Biological Engineering (SHSE:603566) Shareholders Over That Period
Passive investing in an index fund is a good way to ensure your own returns roughly match the overall market. But if you buy individual stocks, you can do both better or worse than that. Unfortunate
Pulike Biological Engineering, Inc. (SHSE:603566) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future?
It is hard to get excited after looking at Pulike Biological Engineering's (SHSE:603566) recent performance, when its stock has declined 20% over the past three months. However, stock prices are usu
Placo (603566.SH): The ban on 1.679,500 restricted shares was lifted on March 19
On March 13, GLONGHUI (603566.SH) announced that the total number of shares in circulation in the company's current stock listing was 1.679,500 shares. The stock listing and circulation date is March 19, 2024.
Placo (603566.SH): Plans to invest 120 million yuan to establish a private equity investment fund
On March 12, GLONGHUI (603566.SH) announced that the company signed the “Luoyang Huizhong Hongtai Venture Capital Partnership (Limited Partnership”) with Huizhong Capital, Luoyang Guohong Capital Venture Capital Co., Ltd. (“Luoyang Industrial Development Fund”), and the “Luoyang Huizhong Hongtai Venture Capital Fund Partnership (Limited Partnership)” (“Partnership Agreement”) to jointly fund the establishment of a Luoyang Huizhong Hongtai Venture Capital Fund partnership (limited partnership). The total fund size is 20 million yuan. The company and subsidiary Luoyang Huizhong Private Equity Fund Management Co., Ltd. (referred to as “Huizhong”
Placo (603566.SH): Products under development include bovine, echinococcosis (echinococcosis) vaccines, etc.
GLONGHUI March 4 | Placo (603566.SH) said on the investor interactive platform that currently the company's vaccine for cattle and sheep is the foot-and-mouth disease vaccine, and the products under development include the bovine and sheep echinococcosis (echinococcosis) vaccine.
Placo (603566.SH): The company did not repurchase shares in February
Glonghui March 1 | Placo (603566.SH) announced that in February 2024, the company did not repurchase shares. As of February 29, 2024, the company has repurchased a total of 1,449,200 shares through centralized bidding transactions. The repurchased shares account for 0.42% of the company's total share capital. The highest repurchased price is 22.48 yuan/share, the lowest price is 15.47 yuan/share, and the total amount paid is 25,410,025 yuan.
Placo (603566.SH): The company is not involved in the financial transfer business
Glonghui, Feb. 19 | Placo (603566.SH) said on the investor interactive platform that the company is not involved in the financial transfer business, and the majority shareholders are not involved in the financial transfer business.
We Think Pulike Biological Engineering (SHSE:603566) Can Stay On Top Of Its Debt
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the permanent loss of capital.' When we think about how risky a company is, we always like
Placo (603566.SH): As of January 31, a total of 1.4492 million shares have been repurchased
Glonghui, January 31 | Placo (603566.SH) announced that as of January 31, 2024, the company had repurchased a total of 1,4492 million shares through centralized bidding transactions. The repurchased shares accounted for 0.42% of the company's total share capital. The highest repurchased price was 22.48 yuan/share, the lowest price was 15.47 yuan/share, and the total amount paid was 25.41 million yuan (excluding transaction fees).
Benign Growth For Pulike Biological Engineering, Inc. (SHSE:603566) Underpins Stock's 27% Plummet
Pulike Biological Engineering, Inc. (SHSE:603566) shareholders won't be pleased to see that the share price has had a very rough month, dropping 27% and undoing the prior period's positive performance
Calculating The Intrinsic Value Of Pulike Biological Engineering, Inc. (SHSE:603566)
Key Insights The projected fair value for Pulike Biological Engineering is CN¥15.32 based on Dividend Discount Model Pulike Biological Engineering's CN¥16.88 share price indicates it is trading at s
Placo (603566.SH) obtained the China National Accreditation Service for Conformity Assessment (CNAS) laboratory accreditation certificate
Placo (603566.SH) issued an announcement. The company recently obtained the China National Accreditation Committee for Conformity Assessment (C...
Pulike Biological Engineering, Inc.'s (SHSE:603566) Last Week's 5.9% Decline Must Have Disappointed Individual Investors Who Have a Significant Stake
Key Insights The considerable ownership by individual investors in Pulike Biological Engineering indicates that they collectively have a greater say in management and business strategy The top 12 sh
Placo (603566.SH): A total of 359,900 shares have been repurchased
Glonghui, January 2, 丨 Placo (603566.SH) announced that as of December 31, 2023, the company had repurchased 359 million shares through centralized bidding transactions. The repurchased shares accounted for 0.10% of the company's total share capital. The highest repurchase price was 22.48 yuan/share, the lowest price was 20.88 yuan/share, and the total amount paid was 7,643,018 yuan (excluding transaction fees).
Placo (603566.SH): There is currently no research in the field of gene editing or synthetic chromosome technology
GLONGHUI December 29丨Placo (603566.SH) said on the investor interactive platform that the company is currently not involved in research in the field of gene editing or synthetic chromosome technology.
Pulike Biological Engineering, Inc.'s (SHSE:603566) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?
Pulike Biological Engineering's (SHSE:603566) stock is up by a considerable 11% over the past month. Given that stock prices are usually aligned with a company's financial performance in the long-te
No Data